The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(2,3-dihydrobenzo[b][1,4]dioxane-6-yl)-3-(3,4-dimethylphenyl)-N-phenyl-4,5-dihydro-1H-pyrazole-1-carbothioamide ID: ALA4292278
PubChem CID: 145986481
Max Phase: Preclinical
Molecular Formula: C26H25N3O2S
Molecular Weight: 443.57
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C2=NN(C(=S)Nc3ccccc3)C(c3ccc4c(c3)OCCO4)C2)cc1C
Standard InChI: InChI=1S/C26H25N3O2S/c1-17-8-9-19(14-18(17)2)22-16-23(20-10-11-24-25(15-20)31-13-12-30-24)29(28-22)26(32)27-21-6-4-3-5-7-21/h3-11,14-15,23H,12-13,16H2,1-2H3,(H,27,32)
Standard InChI Key: SWBCSOCJDZTDAY-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
8.0678 -5.7860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2473 -5.7758 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9815 -6.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6383 -7.0434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3097 -6.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4788 -5.0763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3006 -5.0821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0728 -4.3633 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.2743 -6.9642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5637 -6.5575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8539 -6.9749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8606 -7.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5712 -8.1986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2789 -7.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7125 -4.3762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5342 -4.3820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9488 -3.6710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5428 -2.9580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7223 -2.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3104 -3.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2158 -8.0594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5067 -7.6508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5067 -6.8295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2158 -6.4209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9249 -6.8295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9249 -7.6508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7976 -6.4209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0851 -6.8301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0844 -7.6508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7976 -8.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1429 -6.5720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1553 -8.2047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
6 8 2 0
1 6 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
3 9 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
7 15 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
21 26 1 0
27 28 1 0
28 29 2 0
29 30 1 0
22 30 2 0
23 27 2 0
5 28 1 0
11 31 1 0
12 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 443.57Molecular Weight (Monoisotopic): 443.1667AlogP: 5.62#Rotatable Bonds: 3Polar Surface Area: 46.09Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.99CX Basic pKa: 1.69CX LogP: 6.24CX LogD: 6.24Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.53Np Likeness Score: -1.27
References 1. Li HL, Su MM, Xu YJ, Xu C, Yang YS, Zhu HL.. (2018) Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition., 155 [PMID:29940463 ] [10.1016/j.ejmech.2018.06.043 ]